Identification of a biosurfactant producing strain: Bacillus subtilis HOB2 NIA Haddad, J Wang, B Mu Protein and Peptide letters 16 (1), 7-13, 2009 | 88 | 2009 |
Isolation and characterization of a biosurfactant producing strain, Brevibacilis brevis HOB1 NIA Haddad, J Wang, B Mu Journal of Industrial Microbiology and Biotechnology 35 (12), 1597-1604, 2008 | 86 | 2008 |
Isolation and characterization of a biosurfactant producing strain, Brevibacilis brevis HOB1 NIA Haddad, J Wang, B Mu Journal of Industrial Microbiology and Biotechnology 35 (12), 1597-1604, 2008 | 86 | 2008 |
Variants of Lipopeptides Produced by Bacillus licheniformis HSN221 in Different Medium Components Evaluated by a Rapid Method ESI-MS YM Li, NIA Haddad, SZ Yang, BZ Mu International Journal of Peptide Research and Therapeutics 14, 229-235, 2008 | 70 | 2008 |
Surfactin isoforms from Bacillus subtilis HSO121: separation and characterization NIA Haddad, X Liu, S Yang, B Mu Protein and Peptide Letters 15 (3), 265-269, 2008 | 69 | 2008 |
Structural characterization of eight cyclic lipopeptides produced by Bacillus subtilis HSO121 X Liu, NIA Haddad, S Yang, B Mu Protein and peptide letters 14 (8), 766-773, 2007 | 53 | 2007 |
Purification and some properties of Cu, Zn superoxide dismutase from Radix lethospermi seed, kind of Chinese traditional medicine NIA Haddad, Q Yuan Journal of Chromatography B 818 (2), 123-131, 2005 | 39 | 2005 |
Structural Characterization of Lipopeptides from Brevibacillus brevis HOB1 J Wang, NIA Haddad, SZ Yang, BZ Mu Applied biochemistry and biotechnology 160, 812-821, 2010 | 32 | 2010 |
Optimization of surfactin production by Bacillus subtilis HSO121 through Plackett-Burman and response surface method N IA Haddad, H Gang, J Liu, S Maurice Mbadinga, B Mu Protein and peptide letters 21 (9), 885-893, 2014 | 15 | 2014 |
Correlations of serum chemerin and visfatin with other biochemical parameters in Iraqi individuals with metabolic syndrome and type two diabetes mellitus NI Haddad, E Nori, SA Hamza Jordan Journal of Biological Sciences (JJBS) 4369, 2018 | 10 | 2018 |
Braggs, Scherre, Williamson–Hall and SSP analyses to estimate the variation of crystallites sizes and lattice constants for ZnO nanoparticles synthesized at different temperatures NA Abdulrahman, N Haddad NeuroQuantology 18 (1), 53, 2020 | 6 | 2020 |
Serum Visfatin and Chemerin Levels in Iraqi Diabetics and Obese Individuals NIA Haddad, E Nori, SA Hamza Research Journal of Pharmaceutical, Biological and Chemical Sciences 8 (6 …, 2017 | 6 | 2017 |
Assessment of Monocyte Chemo-Attractant Protein-1 (MCP-1) and Other Biochemical Parameters in Iraqi Pregnant Women IT Ali, NIA Haddad, EA Hussein Iraqi Journal of Science, 4152-4162, 2022 | 5 | 2022 |
The Effect of Type Two Diabetes Mellitus on Superoxide Dismutase (SOD) activity and its correlation with HbA1c in Iraqi Patients NIA Haddad, E Nori, SH Ali Int. J. Eng. Res 2, 7-15, 2016 | 5 | 2016 |
Purification of copper-zinc superoxide dismutase from Semen Lethospermi (SL) by copperchelate affinity chromatography NIA HADDAD, Y Q. S. China Journal Nature Medicine 6 (2), 379-384, 2004 | 4 | 2004 |
Purification of Copper-zinc Superoxide Dismutase from Semen Lethospermi by Copper-chelate Affinity Chromatography NIAH Yuan Chensheng Chin J Nat Med 2 (6), 379-384, 2004 | 4* | 2004 |
Correlation between Albuminuria Levels and Chitinase 3 like 1 Protein in Iraqi Patients with Type 2 Diabetes Mellitus MH Ahmed, NIA Haddad, E Nori Iraqi Journal of Science, 21-32, 2022 | 3 | 2022 |
Correlations of Serum Vitamin D and Thyroid Hormones with Other Biochemical Parameters in Iraqi Pregnant Women with Preeclampsia Disease NIA Haddad Journal of Global Pharma Technology 11 (2), 2019 | 3 | 2019 |
Isolation and purification of superoxide dismutase from Radix Lithospermi Seed NI Haddad, X Wenchao, H Yiwei, Y Qinsheng Pharmaceutical Biotechnology 10 (6), 358-362, 2003 | 3 | 2003 |
Impact of Ischemic Heart Disease on Serum Visfatin, Chemerin and High Sensitivity C - reactive protein in Iraqi Patients with T2 DM SAH Namir I. A. Haddad, Essam Nori Journal of Global Pharma Technology 11 (03), 495-504, 2019 | 2 | 2019 |